Adrenal function in HIV infection

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 17, Issue 3, 2010, Pages 205-209

  Lo, Janet ^a   Grinspoon, Steven K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adrenal gland; Aldosterone; Cortisol; Dehydroepiandrosterone; HIV

Indexed keywords

ADEFOVIR; ALDOSTERONE; ANDROGEN; ANDROSTENEDIONE; CIDOFOVIR; DIDANOSINE; ESTRONE; FLUTICASONE; FUROSEMIDE; HEMOGLOBIN A1C; KETOCONAZOLE; MEGESTROL ACETATE; MINERALOCORTICOID; PENTAMIDINE; PHENYTOIN; POTASSIUM; PRASTERONE; PREDNISOLONE; RIFAMPICIN; RITONAVIR; SODIUM; TENOFOVIR; TESTOSTERONE; TRIAMCINOLONE; TRIMETHOPRIM; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADRENAL DISEASE; ADRENAL FUNCTION; ADRENAL HYPERPLASIA; ADRENAL INSUFFICIENCY; AIDS PATIENT; AIDS RELATED COMPLEX; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; CLINICAL ASSESSMENT; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN TEST; CRYPTOCOCCOSIS; CRYPTOCOCCUS; CUSHING SYNDROME; CYTOMEGALOVIRUS INFECTION; ELECTROLYTE DISTURBANCE; FANCONI RENOTUBULAR SYNDROME; HEALTH CARE PERSONNEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCORTISONE BLOOD LEVEL; HYPERKALEMIA; HYPOALDOSTERONISM; HYPOKALEMIA; HYPONATREMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAABDOMINAL FAT; LUNG TUBERCULOSIS; MEDICAL LITERATURE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NEPHROTOXICITY; NONHUMAN; OPPORTUNISTIC INFECTION; POTASSIUM BLOOD LEVEL; PREMENOPAUSE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TOXOPLASMOSIS; TREATMENT DURATION; TUBULAR DYSFUNCTION;

ADRENAL GLANDS; ALDOSTERONE; GLUCOCORTICOIDS; HIV INFECTIONS; HUMANS; HYDROCORTISONE; MINERALOCORTICOIDS;

EID: 77951804292     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283394441     Document Type: Review

References (43)

1. UNAIDS/WHO. 2009 AIDS Epidemic Update. http://data.unaids.org/pub/ Report/2009/JC1700-Epi-Update-2009-en.pdf
2. Bentley-Lewis R, Adler GK, Perlstein T, et al. Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab 2007; 92:4472-4475. (Pubitemid 350074772)
3. Lo J, Looby SE, Wei J, et al. Increased aldosterone among HIV-infected women with visceral fat accumulation. AIDS 2009; 23:2366-2370.
4. Klein RS, Mann DN, Friedland GH, Surks MI. Adrenocortical function in the acquired immunodeficiency syndrome. Ann Intern Med 1983; 99:566.
5. Greene LW, Cole W, Greene JB, et al. Adrenal insufficiency as a complication of the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101:497-498. (Pubitemid 14018047)
6. Lo JC, Mulligan K, Tai VW, et al. 'Buffalo hump' in men with HIV-I infection. Lancet 1998; 351:871-875.
7. Membreno L, Irony I, Dere W, et al. Adrenocortical function in acquired immune deficiency syndrome. J Clin Endocrinol Metab 1987; 65:482-487. (Pubitemid 17131436)
8. Grinspoon SK, Bilezikian JB. HIV disease and the endocrine system. N Engl J Med 1992; 327:1360-1365.
9. Welch K, Finkbeiner W, Alpers CE, et al. Autopsy findings in the acquired immune deficiency syndrome. J Am Med Assoc 1984; 252:1152-1159. (Pubitemid 14067514)
10. Glasgow BJ, Steinsapir KD, Anders K, Layfield LJ. Adrenal pathology in the acquired immune deficiency syndrome. Am J Clin Path 1985; 84:594-597. (Pubitemid 16235297)
11. Ferreiro J, Vinters HV. Pathology of the pituitary gland in patients with the acquired immune deficiency syndrome (AIDS). Pathology 1988; 20:211-215.
12. Azar S, Melby J. Hypothalamic-pituitary-adrenal function in non-AIDS patients with advanced HIV infection. Am J Med Sci 1993; 305:321-325. (Pubitemid 23145448)
13. Findling JW, Buggy BP, Gilson IH, et al. Longitudinal evaluation of adrenocortical function in patients with the human immunodeficiency virus. J Clin Endocrinol Metab 1994; 79:1091-1096. (Pubitemid 24342253)
14. Bernton EW, Beach JE, Holaday JW, et al. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 1987; 238:519-521. (Pubitemid 17147035)
15. Miller KK, Daly PA, Sentochnik D, et al. Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients. Clin Infect Dis 1998; 27:68-72. (Pubitemid 28334422)
16. Yanovski JA, Miller KD, Kino T, et al. Endocrine and metabolic evaluation of human immunodeficiency virus- infected patients with evidence of protease inhibitor-associated lipodystrophy. J Clin Endocrinol Metab 1999; 84:1925-1931. (Pubitemid 30647011)
17. Grinspoon S, Corcoran C, Stanley T, et al. Mechanisms of androgen deficiency in human immunodeficiency virus-infected women with the wasting syndrome. J Clin Endocrinol Metab 2001; 86:4120-4126. (Pubitemid 32848523)
18. Sutinen J, Kannisto K, Korsheninnikova E, et al. In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing's syndrome is associated with increased regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue. Diabetologia 2004; 47:1668-1671. (Pubitemid 40022399)
19. Norbiato G, Bevilacqua M, Vago T, et al. Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992; 74:608-613.
20. Foisy MM, Yakiwchuk EM, Chiu I, Singh AE. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med 2008; 9:389-396. (Pubitemid 352015642)
21. Danaher PJ, Salsbury TL, Delmar JA. Metabolic derangement after injection of triamcinolone into the hip of an HIV-infected patient receiving ritonavir. Orthopedics 2009; 32:450.
22. Dort K, Padia S, Wispelwey B, Moore CC. Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report. AIDS Res Ther 2009; 6:10.
23. Yombi JC, Maiter D, Belkhir L, et al. Iatrogenic Cushing's syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir. Clin Rheumatol 2008; 27 (Suppl 2):S79-S82.
24. Ramanathan R, Pau AK, Busse KH, et al. Iatrogenic Cushing's syndrome after epidural triamcinolone injections in an HIV type 1 infected patient receiving therapy with ritonavir/lopinavir. Clin Infect Dis 2008; 47:e97-e99. doi: 10.1086/593314.
25. Tortorella C, Guidolin D, Petrelli L, et al. Prolonged zidovudine administration induces a moderate increase in the growth and steroidogenic capacity of the rat adrenal cortex. Int J Mol Med 2009; 23:799-804.
26. Uno K, Konishi M, Yoshimoto E, et al. Fatal cytomegalovirus-associated adrenal insufficiency in an AIDS patient receiving corticosteroid therapy. Intern Med 2007; 46:617-620. (Pubitemid 46845858)
27. KalinMF, Poretsky L, Seres DS, Zumoff B. Hyporeninemic hypoaldosteronism associated with acquired immune deficiency syndrome. Am J Med 1987; 82:1035-1038.
28. Kaile T, Zulu I, Lumayi R, et al. Inappropriately low aldosterone concentrations in adults with AIDS-related diarrhoea in Zambia: a study of response to fluid challenge. BMC Res Notes 2008; 1:10.
29. Rossi GP, Belfiore A, Bernini G, et al. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab 2008; 93:2566-2571. doi: 10.1210/jc.2008- 0251. (Pubitemid 352008521)
30. Choi MJ, Fernandez PC, Patnaik A, et al. Brief report: trimethoprim-induced hyperkalemia in a patient with AIDS. Ann Inter Med 1993; 328:703-706. (Pubitemid 23073373)
31. Lachaal M, Venuto RC. Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated with pentamidine. Am J Med 1989; 87:260-263. (Pubitemid 19234276)
32. Caramelo C, Bello E, Ruiz E, et al. Hyperkalemia in patients infected with the human immunodeficiency virus: involvement of a systemic mechanism. Kidney Int 1999; 56:198-205. (Pubitemid 29300535)
33. Mathew G, Knaus SJ. Acquired Fanconi's syndrome associated with tenofovir therapy. J Gen Intern Med 2006; 21:C3-C5. (Pubitemid 44506861)
34. Tang WW, Kaptein E, Feinstein EI, Massry SG. Hyponatremia in hospitalized patients with the acquired immunodeficiency syndrome (AIDS) and the AIDSrelated complex. Am J Med 1993; 94:169-174. (Pubitemid 23046442)
35. Jacobson MA, Fusaro RE, Galmarini M, Lang W. Decreased serum dehydroepiandrosterone is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200-499. J Infect Dis 1991; 164:864-868.
36. Mulder JW, Frissen PH, Krijnen P, et al. Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virusinfected men. J Infect Dis 1992; 165:413-418.
37. Laudat A, Blum L, Guechot J, et al. Changes in systemic gonadal and adrenal steroids in asymptomatic human immunodeficiency virus-infected men: relationship with CD4 cell counts. Eur J Endocrinol 1995; 133:418-424.
38. Christeff N, De Truchis P, Melchior JC, et al. Longitudinal evolution of HIV-1- associated lipodystrophy is correlated to serum cortisol :DHEA ratio and IFNalpha. Eur J Clin Invest 2002; 32:775-784. (Pubitemid 35334974)
39. Piketty C, Jayle D, Leplege A, et al. Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease. Clin Endocrinol (Oxf) 2001; 55:325-330. (Pubitemid 32823042)
40. Rabkin JG, McElhiney MC, Rabkin R, et al. Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. Am J Psychiatry 2006; 163:59-66. (Pubitemid 43050104)
41. Abrams DI, Shade SB, Couey P, et al. Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled study. AIDS Res Hum Retroviruses 2007; 23:77-85. (Pubitemid 46214175)
42. Poretsky L, Song L, Brillon DJ, et al. Metabolic and hormonal effects of oral DHEA in premenopausal women with HIV infection: a randomized, prospective, placebo-controlled pilot study. Horm Metab Res 2009; 41:244-249.
43. Poretsky L, Brillon DJ, Ferrando S, et al. Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, doubleblind, placebo-controlled trial. Metabolism 2006; 55:858-870. (Pubitemid 43922370)